ZimVie Inc. (NASDAQ:ZIMV) Sees Significant Increase in Short Interest

ZimVie Inc. (NASDAQ:ZIMV) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 400,500 shares, an increase of 16.5% from the February 13th total of 343,900 shares. Approximately 1.5% of the company’s shares are sold short. Based on an average trading volume of 126,700 shares, the days-to-cover ratio is presently 3.2 days.

Institutional Trading of ZimVie

Several institutional investors and hedge funds have recently made changes to their positions in ZIMV. SG Americas Securities LLC increased its position in ZimVie by 15.7% during the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock worth $155,000 after buying an additional 1,508 shares during the period. EMC Capital Management grew its holdings in shares of ZimVie by 47.0% during the fourth quarter. EMC Capital Management now owns 13,802 shares of the company’s stock worth $193,000 after buying an additional 4,414 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of ZimVie by 5.8% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 15,127 shares of the company’s stock valued at $211,000 after purchasing an additional 836 shares during the period. Wells Fargo & Company MN lifted its stake in shares of ZimVie by 17.8% in the 4th quarter. Wells Fargo & Company MN now owns 17,037 shares of the company’s stock worth $238,000 after acquiring an additional 2,569 shares during the period. Finally, Principal Financial Group Inc. purchased a new stake in ZimVie in the 3rd quarter valued at approximately $275,000. 95.63% of the stock is owned by hedge funds and other institutional investors.

ZimVie Stock Performance

Shares of ZIMV stock opened at $11.89 on Thursday. ZimVie has a 12 month low of $11.62 and a 12 month high of $22.40. The company has a market cap of $329.08 million, a P/E ratio of -0.91 and a beta of 2.10. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. The firm has a fifty day moving average price of $13.39 and a 200 day moving average price of $14.29.

ZimVie (NASDAQ:ZIMV) last posted its earnings results on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.02. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The firm had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. Sell-side analysts predict that ZimVie will post 0.6 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reiterated a “hold” rating on shares of ZimVie in a research note on Thursday, March 13th.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.